U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO Profiles

Items: 1 to 20 of 25

1.
High‑risk pathological subtype associated FAM83A‑AS1 promotes malignancy and glycolysis of lung adenocarcinoma via miR‑202‑3p/HK2 axis
Xinkui Xiong, Lei Zhang, Bao Zang, Dafu Xu, Chen Chen, Gaochao Dong, Wenjie Xia, Yanhu Wu
Oncol Rep. 2023 May; 49(5): 95. Published online 2023 Mar 22. doi: 10.3892/or.2023.8532
PMCID:
PMC10086562
AbstractArticlePDF–5.7M
2.
The microRNA-202 as a Diagnostic Biomarker and a Potential Tumor Suppressor
Emad A. Ahmed, Peramaiyan Rajendran, Harry Scherthan
Int J Mol Sci. 2022 Jun; 23(11): 5870. Published online 2022 May 24. doi: 10.3390/ijms23115870
PMCID:
PMC9180238
AbstractArticlePDF–616K
3.
Circulating miRNA-202-3p is a potential novel biomarker for diagnosis of type 1 gastric neuroendocrine neoplasms
Dou Dou, Xiao-kou Li, Qi-sheng Xia, Ying-ying Chen, Yuan-liang Li, Chao Wang, Zhi-rong Qi, Huang-ying Tan
BMC Gastroenterol. 2021; 21: 188. Published online 2021 Apr 23. doi: 10.1186/s12876-021-01769-7
PMCID:
PMC8066967
AbstractArticlePDF–814K
4.
miR-202 Inhibits Cell Proliferation, Migration, and Invasion by Targeting Epidermal Growth Factor Receptor in Human Bladder Cancer
Liqing Zhang, Jianjiang Xu, Gaodi Yang, Heng Li, Xiuxia Guo
Oncol Res. 2018; 26(6): 949–957. Published online 2018 Jul 5. doi: 10.3727/096504018X15149787144385
PMCID:
PMC7844602
AbstractArticlePDF–10M
5.
miR-202 Promotes Cell Apoptosis in Esophageal Squamous Cell Carcinoma by Targeting HSF2
Xiangrui Meng, Xiaoqi Chen, Peng Lu, Wang Ma, Dongli Yue, Lijie Song, Qingxia Fan
Oncol Res. 2017; 25(2): 215–223. Published online 2017 Jan 26. doi: 10.3727/096504016X14732772150541
PMCID:
PMC7840838
AbstractArticlePDF–18M
6.
Silencing miR-202-3p increases MMP-1 and promotes a brain invasive phenotype in metastatic breast cancer cells
Rania Harati, Shirin Hafezi, Aloïse Mabondzo, Abdelaziz Tlili
PLoS One. 2020; 15(10): e0239292. Published online 2020 Oct 1. doi: 10.1371/journal.pone.0239292
PMCID:
PMC7529272
AbstractArticlePDF–3.0M
7.
LncRNA MALAT1 facilitates lung metastasis of osteosarcomas through miR-202 sponging
Jun Zhang, Cheng-Dong Piao, Jie Ding, Zheng-Wei Li
Sci Rep. 2020; 10: 12757. Published online 2020 Jul 29. doi: 10.1038/s41598-020-69574-y
PMCID:
PMC7391763
AbstractArticlePDF–2.6M
8.
Blood microRNA 202-3p associates with the risk of essential hypertension by targeting soluble ST2
Lu Li, Danrong Zhong, Yudan Xie, Xinlei Yang, Zuozhong Yu, Dangui Zhang, Xinghua Jiang, Yanqing Wu, Fangqin Wu
Biosci Rep. 2020 May 29; 40(5): BSR20200378. Published online 2020 May 5. doi: 10.1042/BSR20200378
PMCID:
PMC7201562
AbstractArticlePDF–549K
9.
From incomplete penetrance with normal telomere length to severe disease and telomere shortening in a family with monoallelic and biallelic PARN pathogenic variants
Lois M. Dodson, Alessandro Baldan, Mikael Nissbeck, Sethu M. R. Gunja, Penelope E. Bonnen, Geraldine Aubert, Sherri Birchansky, Anders Virtanen, Alison A. Bertuch
Hum Mutat. Author manuscript; available in PMC 2020 Dec 1.
Published in final edited form as: Hum Mutat. 2019 Dec; 40(12): 2414–2429. Published online 2019 Sep 15. doi: 10.1002/humu.23898
PMCID:
PMC6874886
AbstractArticlePDF–1.0M
10.
MiR-202-5p/PTEN mediates doxorubicin-resistance of breast cancer cells via PI3K/Akt signaling pathway
Tao Liu, Jichao Guo, Xiaoxia Zhang
Cancer Biol Ther. 2019; 20(7): 989–998. Published online 2019 Apr 14. doi: 10.1080/15384047.2019.1591674
PMCID:
PMC6606016
AbstractArticlePDF–4.4M
11.
The long noncoding RNA NORAD enhances the TGF‐β pathway to promote hepatocellular carcinoma progression by targeting miR‐202‐5p
Xuan Yang, Jia‐Bin Cai, Rui Peng, Chuan‐Yuan Wei, Jia‐Cheng Lu, Chao Gao, Zhao‐Zuo Shen, Peng‐Fei Zhang, Xiao‐Yong Huang, Ai‐Wu Ke, Guo‐Ming Shi, Jia Fan
J Cell Physiol. 2019 Jul; 234(7): 12051–12060. Published online 2018 Dec 10. doi: 10.1002/jcp.27869
PMCID:
PMC6590789
AbstractArticlePDF–954K
12.
Up-regulation of microRNA-202-3p in first trimester placenta of pregnancies destined to develop severe preeclampsia, a pilot study
Krishna Singh, John Williams, III, Jordan Brown, Erica T. Wang, Bora Lee, Tania Gonzalez, Jinrui Cui, Mark O Goodarzi, Margareta D. Pisarska
Pregnancy Hypertens. Author manuscript; available in PMC 2018 Oct 1.
Published in final edited form as: Pregnancy Hypertens. 2017 Oct; 10: 7–9. Published online 2017 May 8. doi: 10.1016/j.preghy.2017.04.002
PMCID:
PMC5970562
AbstractArticlePDF–78K
13.
Overexpression of miR-202 resensitizes imatinib resistant chronic myeloid leukemia cells through targetting Hexokinase 2
Yingjun Deng, Xin Li, Jinxin Feng, Xiangliang Zhang
Biosci Rep. 2018 Jun 29; 38(3): BSR20171383. Prepublished online 2018 Mar 20. Published online 2018 May 8. doi: 10.1042/BSR20171383
PMCID:
PMC5938424
AbstractArticlePDF–1.2M
14.
Hsa-miR-202-3p, up-regulated in type 1 gastric neuroendocrine neoplasms, may target DUSP1
Dou Dou, Yan-Fen Shi, Qing Liu, Jie Luo, Ji-Xi Liu, Meng Liu, Ying-Ying Liu, Yuan-Liang Li, Xu-Dong Qiu, Huang-Ying Tan
World J Gastroenterol. 2018 Feb 7; 24(5): 573–582. Published online 2018 Feb 7. doi: 10.3748/wjg.v24.i5.573
PMCID:
PMC5799858
AbstractArticlePDF–1.1M
15.
miR-202 Suppresses Cell Proliferation by Targeting FOXR2 in Endometrial Adenocarcinoma
Xinchao Deng, Congzhe Hou, Zhen Liang, Huali Wang, Lin Zhu, Hui Xu
Dis Markers. 2017; 2017: 2827435. Published online 2017 Jul 30. doi: 10.1155/2017/2827435
PMCID:
PMC5554569
AbstractArticlePDF–1.6M
16.
miR-202 Diminishes TGFβ Receptors and Attenuates TGFβ1-induced EMT in Pancreatic Cancer
Hardik R. Mody, Sau Wai Hung, Rakesh Pathak, Jazmine Griffin, Zobeida Cruz-Monserrate, Rajgopal Govindarajan
Mol Cancer Res. Author manuscript; available in PMC 2018 Aug 1.
Published in final edited form as: Mol Cancer Res. 2017 Aug; 15(8): 1029–1039. Published online 2017 Apr 3. doi: 10.1158/1541-7786.MCR-16-0327
PMCID:
PMC5540775
AbstractArticlePDF–1.7M
17.
A functional variant in ST2 gene is associated with risk of hypertension via interfering MiR‐202‐3p
Fangqin Wu, Lu Li, Qiang Wen, Jinhua Yang, Zhuyue Chen, Peng Wu, Meian He, Xiaomin Zhang, Tangchun Wu, Longxian Cheng
J Cell Mol Med. 2017 Jul; 21(7): 1292–1299. Published online 2017 Jan 25. doi: 10.1111/jcmm.13058
PMCID:
PMC5487927
AbstractArticlePDF–289K
18.
miR-202 inhibits the progression of human cervical cancer through inhibition of cyclin D1
Yuexiong Yi, Huirong Li, Qiongying Lv, Kejia Wu, Wenfen Zhang, Juan Zhang, Dingjun Zhu, Qing Liu, Wei Zhang
Oncotarget. 2016 Nov 1; 7(44): 72067–72075. Published online 2016 Oct 6. doi: 10.18632/oncotarget.12499
PMCID:
PMC5342145
AbstractArticlePDF–2.0M
19.
Down regulation of miR-202 modulates Mxd1 and Sin3A repressor complexes to induce apoptosis of pancreatic cancer cells
Lulu Farhana, Marcia I Dawson, Joseph A Fontana
Cancer Biol Ther. 2015 Jan; 16(1): 115–124. Published online 2015 Jan 22. doi: 10.4161/15384047.2014.987070
PMCID:
PMC4623045
AbstractArticlePDF–623K
20.
Circulating cell-free cancer-testis MAGE-A RNA, BORIS RNA, let-7b and miR-202 in the blood of patients with breast cancer and benign breast diseases
S A Joosse, V Müller, B Steinbach, K Pantel, H Schwarzenbach
Br J Cancer. 2014 Aug 26; 111(5): 909–917. Published online 2014 Jul 1. doi: 10.1038/bjc.2014.360
PMCID:
PMC4150270
AbstractArticlePDF–617K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center